02/14/2025
8:00 AM | Lynx1 Capital Management LP (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:38 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:47 PM | Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:47 PM | Amello Jason (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:52 PM | MacBeath Gavin (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:54 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:54 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 424B5 | |
12/26/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
6:27 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TCRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/16/2024
3:26 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:14 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
7:05 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
3:26 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
11/01/2024
6:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
09/24/2024
4:26 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:46 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:57 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:50 PM | TScan Therapeutics (Subject)
ZDRAVESKI ZORAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:20 PM | Nicholson Garry A (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
3:05 PM | Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:17 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:25 PM | BAKER BROS. ADVISORS LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/17/2024
5:25 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024
4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
9/9 on TSLA from June to January (Ad) Please take a look at THIS case study on Target (TGT)
You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite.
Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured.
And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts! Tap here to catch the TGT case study and learn more |
04/16/2024
3:16 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024
7:17 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free TCRX Stock Alerts